- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 105273 i.v. Placebo
Total 1302 results
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHepatic Insufficiency | HealthyRomania
-
AbbVieBoehringer IngelheimCompletedAsthmaUnited States, Korea, Republic of, Belgium, Taiwan, Canada, Germany, United Kingdom, France, Netherlands, Poland
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Czech Republic, Estonia, Finland, France, Germany, Hungary, Latvia, Norway, Romania, Russian Federation, Slovakia, Spain, Ukraine
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Argentina, Australia, Austria, Canada, Czech Republic, France, Germany, Korea, Republic of, Netherlands, Portugal, Romania, Spain, Switzerland, United Kingdom
-
GeneOne Life Science, Inc.Active, not recruitingSARS-CoV Infection | PneumonitisKorea, Republic of, Puerto Rico, United States, Bulgaria, North Macedonia
-
Boehringer IngelheimCompletedGeneralized Pustular PsoriasisUnited States, Singapore, Korea, Republic of, Germany, Japan, Malaysia, China, France, Thailand, Tunisia, Switzerland, Taiwan
-
Boehringer IngelheimActive, not recruitingSchizophreniaUnited States, United Kingdom, Taiwan, Germany, Bulgaria, Mexico, Argentina, Denmark, Korea, Republic of, Austria, China, Belgium, Czechia, Finland, Serbia, Brazil, Portugal, Lithuania
-
Boehringer IngelheimCompleted
-
Presidio Pharmaceuticals, Inc.Boehringer IngelheimCompletedChronic Hepatitis CUnited States
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesUnited Kingdom
-
AffibodyCovanceCompletedPsoriasis | Healthy SubjectsUnited Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
Boehringer IngelheimCompletedColitis, UlcerativeUnited Kingdom, Denmark, Germany, Spain, Netherlands, Norway
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthyKorea, Republic of
-
Boehringer IngelheimCompleted
-
AbbVieActive, not recruitingCrohn's DiseaseUnited States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Japan, Korea, Republic... and more
-
Boehringer IngelheimCompletedSchizophreniaUnited States, United Kingdom, Australia, Canada, France, New Zealand
-
AbcentraCompletedA Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk FactorsCoronary Artery Disease | Inflammation | Psoriasis | Cardiometabolic SyndromeUnited States
-
Aristotle University Of ThessalonikiUniversity of GlasgowCompleted
-
Boehringer IngelheimCompleted
-
AbbVieCompletedUlcerative Colitis (UC)United States, Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Nether... and more
-
AbbVieBoehringer IngelheimCompleted
-
Boehringer IngelheimTerminatedCOVID-19United States, Spain
-
Jair Bar, M.D., Ph.D.Merck Sharp & Dohme LLCCompletedNon Small Cell Lung Carcinoma | Stage II | Stage IIsrael
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimActive, not recruitingCrohn DiseaseUnited States, Belgium, Germany, Hungary, Spain, United Kingdom, Denmark, Czechia, Poland, Italy, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, Austria, Canada, France, Germany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedKidney Disease, ChronicUnited States, Spain, Korea, Republic of, Belgium, Australia, Hong Kong, India, Canada, China, Germany, Italy, Japan, Malaysia, Finland, Switzerland, Turkey, Hungary, Poland, Portugal, Philippines, Czechia, Greece, Bulgaria, Brazil, Arg... and more
-
AbbVieCompletedCrohn's DiseaseUnited States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Estonia, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Japan, Korea, Republic... and more
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Czech Republic, Russian Federation, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2
-
AbbVieActive, not recruitingPsoriatic ArthritisUnited States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, Estonia, Finland, Germany, Greece, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico and more
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Belgium, Canada, Germany, Russian Federation
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Korea, Republic of, Australia, Italy, United Kingdom, Germany, China, Finland, Denmark, Netherlands, Greece, Argentina, Austria, Chile, Czechia, Hungary, Japan, Poland, Russian Federation, Ukraine
-
Boehringer IngelheimCompletedHepatitis CAustria, Belgium, France, Germany, Japan, Portugal, Romania, Russian Federation, Spain, Switzerland, United Kingdom
-
Boehringer IngelheimCompleted
-
ModernaTX, Inc.National Institute of Allergy and Infectious Diseases (NIAID); Biomedical Advanced...Completed
-
Boehringer IngelheimCompleted